APA (7th ed.) Citation

Hennerici, M. G. (2009). Rationale and design of the prevention of cerebrovascular and cardiovascular events of ischemic origin with Terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovascular diseases, 27, . https://doi.org/10.1159/000209263

Chicago Style (17th ed.) Citation

Hennerici, Michael G. "Rationale and Design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study." Cerebrovascular Diseases 27 (2009). https://doi.org/10.1159/000209263.

MLA (9th ed.) Citation

Hennerici, Michael G. "Rationale and Design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study." Cerebrovascular Diseases, vol. 27, 2009, https://doi.org/10.1159/000209263.